Helmsley Charitable Trust Commits $5 Million to JDRF T1D Fund
Release Date:
10/27/2017
... focused on developing therapies for T1D — including beta cell replacement therapies, a prevention vaccine, immunoregulation and beta cell restoration therapies, implantable glucose monitoring ...
